To include your compound in the COVID-19 Resource Center, submit it here.

Puma launches breast cancer drug Nerlynx in U.S.

Puma Biotechnology Inc. (NASDAQ:PBYI) launched Nerlynx oral neratinib in

Read the full 98 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE